Gene B. Saylors, MD
Medical Oncology and Hematology Specialist
Gene B. Saylors, MD is board certified in Medical Oncology and Internal Medicine. He is a Charleston native and received his Bachelor of Science in Cellular Biology from the University of Georgia. He obtained his Doctorate of Medicine degree from The University of South Carolina School of Medicine. He then entered his internship and completed his residency in Internal Medicine at the University of Alabama at Birmingham. He also completed his fellowship in Hematology and Medical Oncology at The University of Alabama at Birmingham.
Dr. Saylors recently served as a primary investigator in a landmark curative lung cancer trial, enrolling the most patients in the world, and was published in The New England Journal of Medicine. He also has research publications in the Journal of Clinical Oncology, the Journal of General Internal Medicine, and Biology of Blood and Marrow Transplantation. Dr. Saylors serves as the current President of the South Carolina Oncology Society actively working to improve patient care across the state and nationally. He is highly active in clinical research and treats all cancer and blood disorders with a significant interest in gastrointestinal cancer, breast cancer, lung cancer, and skin cancers.
Stories From Dr. Saylors’ Patients
Sara Cox, Stage 4 Lung Cancer
Choose your preferred location
Send UsA Message
Dr. Shelly Shand shares important tips for diagnosing breast cancer early and the latest advancements in breast cancer.
Staying Aware for Breast Cancer Awareness monthCharleston Oncology is proud to sponsor Staying Aware for Breast Cancer Awareness month in conjunction with WCIV News Channel 4. We continue to partner with our community to ensure that every woman has the best chance of...
Early-Stage Breast Cancer Characteristics and Treatment OptionsA rise in early-stage breast cancer diagnosis may result from better screening technology and a raised awareness of the importance of annual mammograms. An early-stage breast cancer diagnosis is contained...
Charleston Oncology’s Clinical Trials most recent non–small cell lung cancer trial enrolled the most people in the world. Gene Saylors, MD, oncologist and hematologist at Charleston Oncology, will present the positive findings at the American Association for Cancer Research 2022 Annual Meeting. “When administering a new trial, we are always cautiously optimistic,” says Dr. Gene Saylors. “The positive results of this Neoadjuvant Lung Trial resulted in rapid FDA approval due to its impressive outcomes.”
Clinical trials for a newly-approved cancer treatment for lung cancer in the Lowcountry helped get the drug ready for people around the world, Lowcountry medical officials say.
How should one go about finding the right oncology practice? We interviewed ten Lowcountry breast cancer patients to get their perspectives and advice.